Evidence map›Paper›PMID 35196517›Full record

ArticleMolecular cell2022

HiCAR is a robust and sensitive method to analyze open-chromatin-associated genome organization.

Xiaolin Wei, Yu Xiang, Derek T Peters, Choiselle Marius, Tongyu Sun, Ruocheng Shan, Jianhong Ou, Xin Lin, Feng Yue, Wei Li and 2 more

Open access · greenAbstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Signal control during tissue regeneration in adult animals.Nature reviews. Molecular cell biology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Elucidation of chromatin loops among regulatory regions using Hi-TrAC.Frontiers in epigenetics and epigenomics · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Xiaolin WeiDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA; Duke Regeneration Center, Duke University Medical Center, Durham, NC 27710, USA.
Yu XiangDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA; Duke Regeneration Center, Duke University Medical Center, Durham, NC 27710, USA.
Derek T PetersDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA; Duke Regeneration Center, Duke University Medical Center, Durham, NC 27710, USA.
Choiselle MariusThe Cell and Molecular Biology Program, Duke University, Durham, NC 27710, USA.
Tongyu SunDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA; Duke Regeneration Center, Duke University Medical Center, Durham, NC 27710, USA.
Ruocheng ShanCenter for Genetic Medicine Research, Center for Cancer and Immunology Research at Children's National Medical Center, Washington, DC 20010, USA.
Jianhong OuDuke Regeneration Center, Duke University Medical Center, Durham, NC 27710, USA.
Xin LinDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA; Duke Regeneration Center, Duke University Medical Center, Durham, NC 27710, USA.
Feng YueDepartment of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Wei LiCenter for Genetic Medicine Research, Center for Cancer and Immunology Research at Children's National Medical Center, Washington, DC 20010, USA.
Kevin W SoutherlandDepartment of Surgery, Division of Vascular and Endovascular Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Yarui DiaoDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA; Duke Regeneration Center, Duke University Medical Center, Durham, NC 27710, USA; Department of Orthopedic Surgery, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: yarui.diao@duke.edu.
Duke University · USChildren's National · USDuke Medical Center · USNorthwestern University · US

Funding

Support for QA/QC for Prior Approval ProcessUL1TR002553 · NCATS · DUKE UNIVERSITY · PI LI, JENNIFER S, MCNAMARA, JAMES O. · 2018 to 2023
$58.5M
The 4D nucleome of muscle regeneration in ischemia-induced tissue damage and repairU01HL156064 · NHLBI · DUKE UNIVERSITY · PI DIAO, YARUI · 2020 to 2024
$3.0M
Multi-omics functional analysis of non-coding regulatory genome for genomic medicineR35HG011328 · NHGRI · DUKE UNIVERSITY · PI DIAO, YARUI · 2020 to 2024
$2.3M
NCATS NIH HHS UL1 TR002553NHGRI NIH HHS R35 HG011328NHLBI NIH HHS U01 HL156064
6 · The paper itself

Abstract

The long-range interactions of cis-regulatory elements (cREs) play a central role in gene regulation. cREs can be characterized as accessible chromatin sequences. However, it remains technically challenging to comprehensively identify their spatial interactions. Here, we report a new method HiCAR (Hi-C on accessible regulatory DNA), which utilizes Tn5 transposase and chromatin proximity ligation, for the analysis of open-chromatin-anchored interactions with low-input cells. By applying HiCAR in human embryonic stem cells and lymphoblastoid cells, we demonstrate that HiCAR identifies high-resolution chromatin contacts with an efficiency comparable with that of in situ Hi-C over all distance ranges. Interestingly, we found that the "poised" gene promoters exhibit silencer-like function to repress the expression of distal genes via promoter-promoter interactions. Lastly, we applied HiCAR to 30,000 primary human muscle stem cells and demonstrated that HiCAR is capable of analyzing chromatin accessibility and looping using low-input primary cells and clinical samples.

Indexed as

ChromatinRegulatory Sequences, Nucleic AcidDNAGene Expression RegulationHumansPromoter Regions, GeneticChromatinDNAchromatin accessibilitychromatin organizationHiCARlow-input multi-omicSilencer-like promoter

Identifiers

PMID35196517
PMCPMC8934281
OpenAlexW4214521951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.